301 related articles for article (PubMed ID: 21062528)
1. Cognitive behavioural therapy for auditory hallucinations: effectiveness and predictors of outcome in a specialist clinic.
Thomas N; Rossell S; Farhall J; Shawyer F; Castle D
Behav Cogn Psychother; 2011 Mar; 39(2):129-38. PubMed ID: 21062528
[TBL] [Abstract][Full Text] [Related]
2. Cognitive behavioral treatment for persons with psychosis: a new direction in psychological intervention.
Freedman S; Hasson-Ohayon I; Roe D
Isr J Psychiatry Relat Sci; 2009; 46(4):298-303. PubMed ID: 20635778
[TBL] [Abstract][Full Text] [Related]
3. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of cognitive functioning for global functional recovery in first-episode schizophrenia.
González-Blanch C; Perez-Iglesias R; Pardo-García G; Rodríguez-Sánchez JM; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
Psychol Med; 2010 Jun; 40(6):935-44. PubMed ID: 19751542
[TBL] [Abstract][Full Text] [Related]
5. Cognitive behavioral therapy and work outcomes: correlates of treatment engagement and full and partial success in schizophrenia.
Kukla M; Davis LW; Lysaker PH
Behav Cogn Psychother; 2014 Sep; 42(5):577-92. PubMed ID: 23790120
[TBL] [Abstract][Full Text] [Related]
6. A randomised controlled trial of acceptance-based cognitive behavioural therapy for command hallucinations in psychotic disorders.
Shawyer F; Farhall J; Mackinnon A; Trauer T; Sims E; Ratcliff K; Larner C; Thomas N; Castle D; Mullen P; Copolov D
Behav Res Ther; 2012 Feb; 50(2):110-21. PubMed ID: 22186135
[TBL] [Abstract][Full Text] [Related]
7. Stabilization of the internal structure of persistent auditory verbal hallucinations in schizophrenia.
Chang JS; Yi JS; Ahn YM; Kim JH; Kim YS
Aust N Z J Psychiatry; 2009 Mar; 43(3):244-51. PubMed ID: 19221913
[TBL] [Abstract][Full Text] [Related]
8. The voices acceptance and action scale (VAAS): Pilot data.
Shawyer F; Ratcliff K; Mackinnon A; Farhall J; Hayes SC; Copolov D
J Clin Psychol; 2007 Jun; 63(6):593-606. PubMed ID: 17457846
[TBL] [Abstract][Full Text] [Related]
9. Compliance and schizophrenia: the predictive potential of insight into illness, symptoms, and side effects.
Kao YC; Liu YP
Compr Psychiatry; 2010; 51(6):557-65. PubMed ID: 20965300
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and effectiveness of individual family intervention on social and clinical functioning and family burden in severe schizophrenia: a 2-year randomized controlled study.
Girón M; Fernández-Yañez A; Mañá-Alvarenga S; Molina-Habas A; Nolasco A; Gómez-Beneyto M
Psychol Med; 2010 Jan; 40(1):73-84. PubMed ID: 19490746
[TBL] [Abstract][Full Text] [Related]
11. Insight: demographic differences and associations with one-year outcome in schizophrenia and schizoaffective disorder.
Wiffen BD; Rabinowitz J; Fleischhacker WW; David AS
Clin Schizophr Relat Psychoses; 2010 Oct; 4(3):169-75. PubMed ID: 20880827
[TBL] [Abstract][Full Text] [Related]
12. Comparison of long-term outcome of schizophrenic, affective and schizoaffective disorders.
Marneros A; Deister A; Rohde A
Br J Psychiatry Suppl; 1992 Oct; (18):44-51. PubMed ID: 1389041
[No Abstract] [Full Text] [Related]
13. Antipsychotic treatment beyond antipsychotics: metacognitive intervention for schizophrenia patients improves delusional symptoms.
Moritz S; Veckenstedt R; Randjbar S; Vitzthum F; Woodward TS
Psychol Med; 2011 Sep; 41(9):1823-32. PubMed ID: 21275083
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a cognitive behaviourally oriented service for relapse prevention in schizophrenia.
Klingberg S; Wittorf A; Fischer A; Jakob-Deters K; Buchkremer G; Wiedemann G
Acta Psychiatr Scand; 2010 May; 121(5):340-50. PubMed ID: 19895624
[TBL] [Abstract][Full Text] [Related]
15. A preliminary exploration of predictors of outcome and cognitive mechanisms of change in cognitive behaviour therapy for psychosis in people not taking antipsychotic medication.
Morrison AP; Turkington D; Wardle M; Spencer H; Barratt S; Dudley R; Brabban A; Hutton P
Behav Res Ther; 2012 Feb; 50(2):163-7. PubMed ID: 22209267
[TBL] [Abstract][Full Text] [Related]
16. Enhancing treatment fidelity in psychotherapy research: novel approach to measure the components of cognitive behavioural therapy for relapse prevention in first-episode psychosis.
Alvarez-Jimenez M; Wade D; Cotton S; Gee D; Pearce T; Crisp K; McGorry PD; Gleeson JF
Aust N Z J Psychiatry; 2008 Dec; 42(12):1013-20. PubMed ID: 19016089
[TBL] [Abstract][Full Text] [Related]
17. Is memory impairment a rate limiter in cognitive behavioural therapy for chronic schizophrenia?
Penadés R; Catalán R; Pujol N; Puig O; Guarch J; Masana G; Navarro V; Gastó C
Psychother Psychosom; 2010; 79(2):129-30. PubMed ID: 20090401
[No Abstract] [Full Text] [Related]
18. The reliability and validity of the Test of Adaptive Behavior in Schizophrenia (TABS).
Velligan DI; Diamond P; Glahn DC; Ritch J; Maples N; Castillo D; Miller AL
Psychiatry Res; 2007 May; 151(1-2):55-66. PubMed ID: 17379319
[TBL] [Abstract][Full Text] [Related]
19. Cognitive behaviour therapy in patients with schizophrenia who are not prescribed antipsychotic medication: a case series.
Christodoulides T; Dudley R; Brown S; Turkington D; Beck AT
Psychol Psychother; 2008 Jun; 81(Pt 2):199-207. PubMed ID: 18230197
[TBL] [Abstract][Full Text] [Related]
20. Acute-phase and 1-year follow-up results of a randomized controlled trial of CBT versus Befriending for first-episode psychosis: the ACE project.
Jackson HJ; McGorry PD; Killackey E; Bendall S; Allott K; Dudgeon P; Gleeson J; Johnson T; Harrigan S
Psychol Med; 2008 May; 38(5):725-35. PubMed ID: 18005494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
